Ganga Pharmaceuticals quarterly results and financials

Ganga Pharmaceuticals (BSE 539680)₹12.50+4.17%(8 Sept 2026 close)Pharmaceuticals

Key facts

In the Mar 2026 quarter (standalone), Ganga Pharmaceuticals reported sales of ₹1.45 Cr, up 9.8% from Mar 2025, and net profit of ₹0.07 Cr, up 40.0% year on year. For the year to Mar 2026, sales were ₹2.66 Cr and net profit ₹0.09 Cr.

Sales (Mar 2026): ₹1.45 Cr
Net profit (Mar 2026): ₹0.07 Cr
Sales (FY Mar 2026): ₹2.66 Cr
Net profit (FY Mar 2026): ₹0.09 Cr
EPS (Mar 2026): ₹0.13
Borrowings (Mar 2026): ₹1.09 Cr

Company filings, standalone accounts; latest reported quarter Mar 2026

Ganga Pharmaceuticals quarterly results

₹ crore unless stated; each column is a quarter.

Ganga Pharmaceuticals Quarterly results
	Mar 2023	Sep 2023	Mar 2024	Sep 2024	Mar 2025	Sep 2025	Mar 2026
Sales	1.22	1.31	1.41	1.30	1.32	1.36	1.45
Expenses	1.31	1.28	1.42	1.43	1.34	1.40	1.40
Operating Profit	−0.08	0.06	0.02	−0.12	0.00	−0.03	0.08
OPM %	−5.7%	3.8%	0.7%	−8.5%	0.0%	−1.5%	4.8%
Other Income	0.19	0.08	0.16	0.30	0.15	0.14	0.12
Interest	0.08	0.10	0.10	0.10	0.10	0.08	0.08
Depreciation	0.02	0.02	0.01	0.01	0.01	0.02	0.02
Profit before tax	0.00	0.01	0.04	0.06	0.02	0.02	0.09
Tax %	0.0%	50.0%	20.0%	57.1%	−66.7%	33.3%	20.0%
Net Profit	0.00	0.01	0.02	0.01	0.05	0.01	0.07
EPS (Rs)	0.01	0.04	0.05	0.03	0.11	0.02	0.13

Ganga Pharmaceuticals profit and loss

₹ crore unless stated; years end in March. TTM is the last four quarters.

Ganga Pharmaceuticals Profit and loss
	Mar 2015	Mar 2016	Mar 2017	Mar 2018	Mar 2019	Mar 2020	Mar 2021	Mar 2022	Mar 2023	Mar 2024	Mar 2025	Mar 2026
Sales	2.43	2.44	2.62	2.72	3.17	2.98	2.26	2.31	2.46	2.57	2.47	2.66
Expenses	2.20	2.16	2.33	2.42	2.77	2.62	2.25	2.29	2.48	2.54	2.61	2.64
Operating Profit	0.26	0.31	0.32	0.33	0.43	0.39	0.04	0.05	0.00	0.06	−0.13	0.05
OPM %	10.2%	12.2%	11.7%	11.7%	13.2%	12.6%	1.3%	1.7%	0.0%	1.9%	−4.9%	1.5%
Other Income	0.16	0.15	0.15	0.16	0.13	0.18	0.26	0.25	0.31	0.25	0.45	0.27
Interest	0.34	0.34	0.33	0.29	0.26	0.25	0.20	0.20	0.20	0.19	0.19	0.14
Depreciation	0.03	0.03	0.03	0.05	0.04	0.04	0.04	0.04	0.05	0.04	0.04	0.05
Profit before tax	0.04	0.06	0.10	0.12	0.25	0.25	0.03	0.05	0.04	0.05	0.08	0.12
Tax %	40.0%	28.6%	27.3%	23.1%	30.7%	23.1%	50.0%	16.7%	40.0%	33.3%	11.1%	23.1%
Net Profit	0.02	0.04	0.06	0.08	0.18	0.18	0.01	0.03	0.03	0.04	0.07	0.09
EPS (Rs)	0.12	0.11	0.16	0.21	0.46	0.46	0.04	0.09	0.09	0.09	0.16	0.16
Dividend payout %	0.0%	0.0%	0.0%	0.0%	0.0%	0.0%	0.0%	0.0%	0.0%	0.0%	0.0%	0.0%

Ganga Pharmaceuticals balance sheet

₹ crore, at each year end.

Ganga Pharmaceuticals Balance sheet
	Mar 2015	Mar 2016	Mar 2017	Mar 2018	Mar 2019	Mar 2020	Mar 2021	Mar 2022	Mar 2023	Mar 2024	Mar 2025	Mar 2026
Equity Capital	2.33	4.05	4.04	4.04	4.04	4.05	4.05	4.05	4.05	4.83	4.82	5.89
Reserves	0.31	0.74	0.81	0.91	1.09	1.29	1.31	1.35	1.39	2.21	2.28	2.39
Borrowings	2.14	2.18	2.13	2.04	1.86	1.47	1.73	1.93	1.83	1.36	1.41	1.09
Other Liabilities	0.61	0.35	0.59	1.21	0.74	0.74	0.55	0.65	0.71	0.24	0.42	0.25
Total Liabilities	5.39	7.32	7.57	8.20	7.73	7.55	7.64	7.98	7.98	8.64	8.93	9.62
Fixed Assets	0.66	0.61	0.61	0.81	0.79	0.75	0.71	0.67	0.65	0.62	0.65	0.66
CWIP	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Investments	0.06	0.51	0.00	0.00	0.10	0.10	0.10	0.10	0.10	0.10	0.00	0.00
Other Assets	4.67	6.20	6.96	7.39	6.84	6.70	6.83	7.21	7.23	7.92	8.28	8.96
Inventories	1.04	1.15	1.13	1.15	1.14	1.03	1.12	1.14	1.19	1.23	1.17	1.16
Trade receivables	0.74	0.95	1.26	1.59	1.24	1.08	0.83	0.90	0.90	0.93	0.92	0.95
Cash & equivalents	0.19	0.21	0.56	0.30	0.25	0.02	0.02	0.03	0.02	0.04	0.29	0.07
Total Assets	5.39	7.32	7.57	8.20	7.73	7.55	7.64	7.98	7.98	8.64	8.93	9.62

Ganga Pharmaceuticals cash flow

₹ crore, for each year.

Ganga Pharmaceuticals Cash flow
	Mar 2015	Mar 2016	Mar 2017	Mar 2018	Mar 2019	Mar 2020	Mar 2021	Mar 2022	Mar 2023	Mar 2024	Mar 2025	Mar 2026
Cash from operating activity	0.26	−1.04	0.04	0.23	0.10	−0.30	−0.17	−0.20	−0.03	−1.25	−0.57	−1.30
Cash from investing activity	−0.17	−0.82	0.61	−0.13	0.27	0.36	0.27	0.18	0.48	0.12	1.17	0.23
Cash from financing activity	−0.07	1.91	−0.34	−0.37	−0.46	−0.30	−0.11	0.04	−0.45	1.15	−0.34	0.83
Net cash flow	0.04	0.03	0.34	−0.27	−0.06	−0.23	0.00	0.02	0.02	0.00	0.28	−0.25
Capex	0.03	0.00	0.03	0.25	0.02	0.00	0.01	0.00	0.00	0.01	0.09	0.03
Free cash flow	0.22	−1.05	0.00	−0.01	0.07	−0.31	−0.19	−0.21	−0.04	−1.27	−0.67	−1.34
CFO / OP %	104.0%	−347.1%	28.9%	88.0%	40.0%	−66.1%	−567.0%	−500.1%	—	−2,480.1%	466.9%	−3,200.0%

Ganga Pharmaceuticals ratios

Working-capital days and returns, by year.

Ganga Pharmaceuticals Ratios
	Mar 2015	Mar 2016	Mar 2017	Mar 2018	Mar 2019	Mar 2020	Mar 2021	Mar 2022	Mar 2023	Mar 2024	Mar 2025	Mar 2026
Debtor days	108	139	172	210	140	130	131	139	131	129	133	128
Inventory days	289	376	387	360	342	298	334	332	348	363	354	330
Days payable	119	100	184	331	164	161	131	153	172	30	85	35
Cash conversion cycle	279	416	377	240	319	267	335	318	308	463	403	423
Working capital days	142	468	429	417	388	449	478	503	477	639	731	856
ROCE %	8.0%	6.8%	6.2%	5.9%	7.3%	7.3%	3.3%	3.5%	3.3%	3.1%	3.2%	2.9%

Ganga Pharmaceuticals: frequently asked questions

What are the latest quarterly results of Ganga Pharmaceuticals?

For the Mar 2026 quarter, Ganga Pharmaceuticals reported sales of ₹1.45 Cr, up 9.8% year on year and net profit of ₹0.07 Cr, up 40.0% year on year. The operating margin was 4.8%.

What is the annual revenue of Ganga Pharmaceuticals?

Ganga Pharmaceuticals' sales for the year to Mar 2026 were ₹2.66 Cr.

What is the net profit of Ganga Pharmaceuticals?

Net profit for the year to Mar 2026 was ₹0.09 Cr. Earnings per share over the same trailing period were ₹0.16.

How much debt does Ganga Pharmaceuticals have?

Ganga Pharmaceuticals reported borrowings of ₹1.09 Cr at Mar 2026, against cash and equivalents of ₹0.07 Cr.

What is the free cash flow of Ganga Pharmaceuticals?

Cash from operations was −₹1.30 Cr in the year to Mar 2026; after capital spending, free cash flow was −₹1.34 Cr.

Loading…